Form 4: Electromed Director Andrew Summers Acquires Shares
Insider Transaction Report
Electromed Director Andrew Summers acquired 3,000 shares of common stock as restricted stock, scheduled to vest in June 2026, bringing his direct beneficial ownership to 12,000 shares.
Summary
- Andrew Summers, a Director of Electromed, Inc. (ELMD), acquired 3,000 shares of common stock.
- The transaction occurred on December 1, 2025, and was made pursuant to a Rule 10b5-1(c) plan.
- The acquired shares are restricted stock, scheduled to vest on June 1, 2026, unless earlier accelerated or terminated.
- The acquisition price for these shares was $0.
- Following this transaction, Andrew Summers directly beneficially owns 12,000 shares of common stock.
- Andrew Summers also indirectly beneficially owns 270,367 shares through Summers Value Fund LP, where he is a Managing Member and disclaims beneficial ownership except to the extent of his pecuniary interest.
Sentiment
Score: 6
Explanation: Slightly positive, as a director acquiring shares (even restricted stock) can be interpreted as a sign of confidence in the company's future, though the $0 price indicates it's likely a grant rather than an open market purchase.
Positives
- A Director acquiring shares, even restricted stock, can signal confidence in the company's future prospects.
- The transaction was pre-planned under a Rule 10b5-1(c) plan, indicating a structured approach to insider transactions.
Future Outlook
The 3,000 restricted shares acquired by Director Andrew Summers are scheduled to vest on June 1, 2026, indicating a future milestone for these specific holdings.
Industry Context
Insider transactions, such as director stock acquisitions, are routinely monitored by investors as they can provide insights into management's perspective on the company's valuation and future performance. The use of a Rule 10b5-1(c) plan is a common practice for insiders to manage their stock transactions in compliance with SEC regulations.
Related Party Transactions
- Andrew Summers indirectly beneficially owns 270,367 shares through Summers Value Fund LP. Mr. Summers, as the Managing Member of Summers Value Partners GP LLC (general partner of Summers Value Fund) and Summers Value Partners LLC (investment manager of Summers Value Fund), may be deemed to beneficially own these securities, though he expressly disclaims beneficial ownership except to the extent of his pecuniary interest therein.
Stakeholder Impact
- Shareholders may view the director's acquisition of shares as a positive signal regarding the company's future prospects and management's alignment with shareholder interests.
Next Steps
- Vesting of the 3,000 restricted shares on June 1, 2026.
Key Dates
| Date | Description |
|---|---|
| 12/01/2025 | Date of transaction for the acquisition of 3,000 shares of common stock. |
| 12/03/2025 | Date the Form 4 was signed by the attorney-in-fact for Andrew Summers. |
| 06/01/2026 | Scheduled vesting date for the 3,000 restricted shares acquired. |
Keywords
Electromed, ELMD, Form 4, Insider Transaction, Director, Stock Acquisition, Restricted Stock, Beneficial Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.